Work

The Fast and the Furious: Chasing a Clinical Niche for COVID-19 Convalescent Plasma

Year: 2022

Type: editorial

Abstract: The Association for the Advancement of Blood and Biotherapies reported a thorough analysis of existing data and guidelines for the use of COVID-19 convalescent plasma (CCP) for treatment and prophylaxis of COVID-19. The editorialists discuss the recommendations, how they compare with recommendations from other entities, and the lessons the experience with CCP provides for the use of passive immunotherapy for future emerging infectious diseases.

Source: Annals of Internal Medicine

DOI: 10.7326/m22-2329

Authors: Jason V. Baker, H. Clifford Lane

Institutions: University of Minnesota, National Institutes of Health, National Institute of Allergy and Infectious Diseases

Language: English

Topic: COVID-19 Clinical Research Studies

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W4291690956

Cites: 9

Cited by: 3

Related to: 10